These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9815969

  • 1. Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.
    Ciardiello F, Damiano V, Bianco C, di Isernia G, Ruggiero A, Caraglia M, Tagliaferri P, Baselga J, Mendelsohn J, Bianco AR.
    Clin Cancer Res; 1995 Feb; 1(2):161-7. PubMed ID: 9815969
    [Abstract] [Full Text] [Related]

  • 2. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
    Ciardiello F, Tortora G.
    Clin Cancer Res; 1998 Apr; 4(4):821-8. PubMed ID: 9563874
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
    Ciardiello F, Damiano V, Bianco R, Bianco C, Fontanini G, De Laurentiis M, De Placido S, Mendelsohn J, Bianco AR, Tortora G.
    J Natl Cancer Inst; 1996 Dec 04; 88(23):1770-6. PubMed ID: 8944008
    [Abstract] [Full Text] [Related]

  • 4. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
    Normanno N, Tortora G, De Luca A, Pomatico G, Casamassimi A, Agrawal S, Mendelsohn J, Bianco AR, Ciardiello F.
    Oncol Rep; 1999 Dec 04; 6(5):1105-9. PubMed ID: 10425310
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C, Bianco R, Tortora G, Damiano V, Guerrieri P, Montemaggi P, Mendelsohn J, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2000 Nov 04; 6(11):4343-50. PubMed ID: 11106252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
    Tortora G, Caputo R, Damiano V, Caputo R, Troiani T, Veneziani BM, De Placido S, Bianco AR, Zangemeister-Wittke U, Ciardiello F.
    Clin Cancer Res; 2003 Feb 04; 9(2):866-71. PubMed ID: 12576461
    [Abstract] [Full Text] [Related]

  • 8. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G, Caputo R, Damiano V, Melisi D, Bianco R, Fontanini G, Veneziani BM, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2003 Apr 04; 9(4):1566-72. PubMed ID: 12684433
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro.
    Ohmura E, Wakai K, Isozaki O, Murakami H, Onoda N, Emoto N, Shizume K, Tsushima T, Demura H, Robins RK.
    Br J Cancer; 1993 Feb 04; 67(2):279-83. PubMed ID: 8381655
    [Abstract] [Full Text] [Related]

  • 10. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
    Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, Pepe S, Bianco AR, Agrawal S, Mendelsohn J, Tortora G.
    J Natl Cancer Inst; 1998 Jul 15; 90(14):1087-94. PubMed ID: 9672257
    [Abstract] [Full Text] [Related]

  • 11. Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.
    Tortora G, Caputo R, Pomatico G, Pepe S, Bianco AR, Agrawal S, Mendelsohn J, Ciardiello F.
    Clin Cancer Res; 1999 Apr 15; 5(4):875-81. PubMed ID: 10213224
    [Abstract] [Full Text] [Related]

  • 12. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells.
    Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, Hong SH.
    Int J Cancer; 2001 Jul 01; 93(1):33-41. PubMed ID: 11391618
    [Abstract] [Full Text] [Related]

  • 13. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.
    Carlson CC, Chinery R, Burnham LL, Dransfield DT.
    Neoplasia; 2000 Jul 01; 2(5):441-8. PubMed ID: 11191111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
    Noguchi K, Murata T, Cho-Chung YS.
    Eur J Cancer; 1998 Jul 01; 34(8):1260-7. PubMed ID: 9849489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.